Home > Food & Beverages > Nutraceuticals > Apigenin Market

Apigenin Market Size

  • Report ID: GMI6008
  • Published Date: Jun 2023
  • Report Format: PDF

Apigenin Market Size

Apigenin Market size reached USD 300 thousand in 2022 and is estimated to grow at over 3.8% CAGR between 2023 and 2032. The market for natural and plant-based ingredients is witnessing significant growth as consumers increasingly seek healthier and more sustainable options. The rising demand for natural and plant-based products in industries such as pharmaceuticals, cosmetics, and food and beverages will stimulate business development

 

 

 

As consumers become more health-conscious and seek natural remedies and supplements, the awareness and demand for apigenin as a dietary supplement or ingredient in functional foods and beverages are increasing. The growing body of research supporting the health benefits of apigenin is driving market growth.

 

One pitfall for the apigenin market could be the limited availability and extraction challenges. Although apigenin is naturally present in several plant sources, extracting it in large quantities can be challenging and costly. The limited availability and extraction difficulties may result in potential supply constraints, leading to fluctuations in pricing and availability of apigenin. Moreover, the reliance on specific plant sources for apigenin extraction raises concerns about sustainability and potential environmental impacts, necessitating careful management and alternative sourcing strategies to mitigate these challenges.

Authors: Kiran Pulidindi, Kunal Ahuja

Frequently Asked Questions (FAQ) :

The market size of apigenin was valued at around USD 300 Thousand in 2022 and is estimated to surpass USD 435.5 Thousand by 2032, backed by the potential health benefits and therapeutic properties of the product which favors its demand across pharmaceuticals, cosmetics, and food & beverages sectors.

Apigenin market revenue from pharma & healthcare segment exceeded USD 127.2 thousand in 2022 and will reach USD 191.2 thousand by 2032, as the product is extensively utilized for its potential therapeutic properties, including its antioxidant, anti-inflammatory, anticancer, neuroprotective, and antimicrobial effects.

North America marker for apigenin crossed USD 144.1 thousand in 2022 and is expected to reach USD 209.7 thousand by 2032, owing to the consumer preference for natural ingredients, and a rising demand for plant-based ingredients in various industries, including pharmaceuticals, nutraceuticals, and cosmetics.

Indofine Chemical Company Inc., Cayman Chemical Company, TCI Chemicals, Sigma-Aldrich (Merck KGaA), ChemFaces, and Extrasynthese.

Apigenin Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 176
  • Countries covered: 18
  • Pages: 300
 Download Free Sample